title: Mechanism of increased serum soluble interleukin-2 receptor levels in patients on continuous ambulatory peritoneal dialysis.
abstract: OBJECTIVE
  The aim of this study was to investigate the mechanism underlying the increase of serum soluble interleukin-2 receptor (IL-2R) levels in patients on continuous ambulatory peritoneal dialysis.
  
  
  METHODS
  In 13 dialysis patients and 17 healthy controls, serum soluble IL-2R levels were determined by enzyme-linked immunosorbent assay, and CD25-positive (cell surface IL-2R-positive) cells were detected by flow cytometry. Soluble IL-2R levels were also measured in the supernatant of cultured peripheral blood mononuclear cells.
  
  
  RESULTS
  The serum soluble IL-2R level was significantly higher in the patients than in the healthy controls (p < 0.0001). In contrast, both the percentage and the absolute count of CD25-positive cells showed no significant differences, and neither did the soluble IL-2R level in culture supernatant. Serum soluble IL-2R levels showed a positive correlation with the serum beta2-microglobulin level (p < 0.01), the age of the patients (p < 0.05), and duration of dialysis (p < 0.05), as well as a negative correlation with the urine volume (p < 0.05).
  
  
  CONCLUSIONS
  The increase of serum soluble IL-2R in patients on peritoneal dialysis may be caused by accumulation due to its low transperitoneal clearance and low urinary excretion.
authors: The Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima City, Japan.
authors: A
authors: A
authors: Takemasa
authors: N
authors: N
authors: Yorioka
authors: H
authors: H
authors: Oda
authors: D
authors: D
authors: Amimoto
authors: T
authors: T
authors: Ito
authors: M
authors: M
authors: Yamakido
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy*; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory; D015375:Receptors, Interleukin-2 / Q000097:blood*
chemical_list: D015375:Receptors, Interleukin-2